Charles River Laboratories International, Inc.
CRL · FY2025 · Fiscal year ended Dec 27, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $4.02B | $4.05B | −0.9% |
| Operating income | $25.2M | $227M | −88.9% |
| Net income | −$144M | $22.2M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 26, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $983M | $1.00B | −2.2% |
| Operating income | $203M | $134M | +51.4% |
| Net income | $333M | $54.4M | +512% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Charles River's revenue in FY2025?
- $4.02B in FY2025 (Fiscal year ended Dec 27, 2025), −0.9% vs $4.05B a year earlier, per its 10-K filed Feb 2026.
- Was Charles River profitable in FY2025?
- No: net income was −$144M and operating income $25.2M in FY2025.
- What was Charles River's revenue in Q3 2026?
- $983M (−2.2% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.